Abstract
Diabetes at advanced age increases rise of cognitive impairment, but its potential mechanisms are still far from being fully understood. In this study, we analyzed the metabolic alterations in six different brain regions between streptozotocin (STZ)-induced diabetic mice with cognitive decline (DM) and age-matched controls (CON) using a 1H NMR-based metabolomics approach, to explore potential metabolic mechanisms underlying diabetes-induced cognitive decline. The results show that DM mice had a peculiar metabolic phenotype in all brain regions, mainly involving increased lactate level, decreased choline and energy metabolism as well as disrupted astrocyte-neuron metabolism. Furthermore, these metabolic changes exhibited a brain region-specific pattern. Collectively, our results suggest that brain region-specific metabolic disorders may be responsible for diabetes-induced cognitive dysfunction.
Similar content being viewed by others
Abbreviations
- T1D:
-
type 1 diabetes
- CON:
-
normal mice
- DM:
-
diabetes mellitus
- STZ:
-
streptozotocin
- MWM:
-
Morris water maze
- Ala:
-
alanine
- ADP:
-
adenosine diphosphate
- AMP:
-
adenosine monophosphate
- Asp:
-
aspartate
- Cho:
-
choline
- Cre:
-
creatine
- Fum:
-
fumarate
- GABA:
-
γ -aminobutyric acid
- Gln:
-
glutamine
- Glu:
-
glutamate
- Gly:
-
glycine
- IMP:
-
inosine monophosphate
- Ino:
-
inosine
- Lac:
-
lactate
- Myo:
-
myo-inositol
- NAA:
-
N-acetylaspartate
- GPC:
-
glycerophosphorylcholine
- Tau:
-
taurine
- Cor:
-
cortex
- Cer:
-
cerebellum
- Hip:
-
hippocampus
- Hyp:
-
hypothalamus
- Mid:
-
midbrain
- Str:
-
striatum
References
Akimoto H, Oshima S, Sugiyama T, Negishi A, Nemoto T, Kobayashi D (2019) Changes in brain metabolites related to stress resilience: Metabolomic analysis of the hippocampus in a rat model of depression. Behav Brain Res 359:342–352
Andersen JV, Nissen JD, Christensen SK, Markussen KH, Waagepetersen HS (2017) Impaired hippocampal glutamate and glutamine metabolism in the db/db mouse model of type 2 diabetes mellitus. Neural Plast 2017:1–9
Azhir Z, Dehghanian F, Hojati Z (2018) Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes. Mol Biol Rep 45(6):1973–1980
Bakker FC, Klijn CJ, Jennekens-Schinkel A, van der Tweel I, van der Grond J, van Huffelen AC et al (2003) Cognitive impairment is related to cerebral lactate in patients with carotid artery occlusion and ipsilateral transient ischemic attacks. Stroke 34(6):1419–1424
Beetsch JW, Olson JE (1998) Taurine synthesis and cysteine metabolism in cultured rat astrocytes: effects of hyperosmotic exposure. Am J Physiol-Cell Physiol 274(4):866–874
Bélanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14(6):724–738
Blusztajn J, Slack B, Mellott T (2017) Neuroprotective actions of dietary choline. Nutrients 9(8):815
Bowery NG, Smart TG (2006) GABA and glycine as neurotransmitters: a brief history. Br J Pharmacol 147(S1):109–119
Brands AMA, Biessels GJ, Haan EHFD, Kappelle LJ, Kessels RPC (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735
Burkart V, Wang ZQ, Jürgen R, Heller B, Kolb H (1999) Mice lacking the poly (ADP-ribose) polymerase gene are resistant to beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5:314–319
Ceretta LB, Réus GZ, Rezin GT, Scaini G, Streck EL, Quevedo J (2010) Brain energy metabolism parameters in an animal model of diabetes. Metab Brain Dis 25:391–396
Chomova M, Balazova M, Muchova J (2017) Diabetes-induced abnormalities of mitochondrial function in rat brain cortex: the effect of n-3 fatty acid diet. Mol Cell Biochem 435:109–131
De Feyter HM, Mason GF, Shulman GI, Rothman DL, Petersen KF (2013) Increased brain lactate concentrations without increased lactate oxidation during hypoglycemia in type 1 diabetic individuals. Diabetes 62:3075–3080
Duarte JM (2015) Metabolic alterations associated to brain dysfunction in diabetes. Aging Dis 6(5):304
Flood JF, Mooradian AD, Morley JE (1990) Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 39(11):1391–1398
Gilmour G, Dix S, Fellini L, Gastambide F, Plath N, Steckler T et al (2012) NMDA receptors, cognition and schizophrenia–testing the validity of the NMDA receptor hypofunction hypothesis. Neuropharmacology 62:1401–1412
Gonzalez-Riano C, Garcia A, Barbas C (2016) Metabolomics studies in brain tissue: A review. J Pharm Biomed Anal 130:141–168
Hansen TM, Brock B, Juhl A, Drewes AM, Vorum H, Andersen CU et al (2019) Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes. J Diabetes Complications 33:323–328
Harsing LG Jr, Matyus P (2013) Mechanisms of glycine release, which build up synaptic and extrasynaptic glycine levels: The role of synaptic and non-synaptic glycine transporters. Brain Res Bull 93:110–119
Hletala K, Harjutsalo V, Forsblom C, Groop PH, Flnndlane Study Group (2010) Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care 33(6):1315–1319
Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Ann Rev Pharmacol Toxicol 48:653–683
Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27–30
Lalande J, Halley H, Balayssac S, Gilard V, Dejean S, Martino R et al (2014) ) 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer’s disease at four ages. J Alzheimer’s Dis 39(1):121–143
Lee J, Choi J, Wong GW, Wolfgang MJ (2016) Neurometabolic roles of ApoE and Ldl-R in mouse brain. J Bioenerg Biomembr 48(1):13–21
Lenzen S (2008) The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 51(2):216–226
Liapi C, Kyriakaki A, Zarros A, Galanopoulou P, Al-Humadi H, Dontas I et al (2010) Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy. Metab Brain Dis 25:269–276
Liguori C, Stefani A, Sancesario G, Sancesario GM, Marciani MG, Pierantozzi M (2015) CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer’s disease. J Neurol Neurosur Psych 86(6):655–659
Liu CC, Chen JL, Chang XR, Shen JC, Lian LY, Wang YD et al (2017) Comparative metabolomics study on therapeutic mechanism of electro-acupuncture and moxibustion on rats with chronic atrophic gastritis (CAG). Sci Rep 7(1):14362
Ma RC (2018) Epidemiology of diabetes and diabetic complications in China. Diabetologia 61(6):1249–1260
MacNaught N, Holt P (2015) Type 1 diabetes and alcohol consumption. Nursing Stand 29(50):41
Mikk ML, Heikkinen T, El-Amir MI, Kiviniemi M, Laine AP, Härkönen T et al (2017) The association of the HLA‐A* 24: 02, B* 39: 01 and B* 39: 06 alleles with type 1 diabetes is restricted to specific HLA‐DR/DQ haplotypes in Finns. Hla 89(4):215–224
Miyata S, Matsushima O, Hatton GI (1997) Taurine in rat posterior pituitary: localization in astrocytes and selective release by hypoosmotic stimulation. J Comp Neurol 381(4):513–523
Mora-Ortiz M, Ramos PN, Oregioni A, Claus SP (2019) NMR metabolomics identifies over 60 biomarkers associated with type ii diabetes impairment in db/db mice. Metabolomics 15:89
Murata M, Takahashi A, Saito I, Kawanishi S (1999) Site-specific dna methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem Pharmacol 57:881–887
Murfitt SA, Zaccone P, Wang X, Acharjee A, Sawyer Y, Koulman A et al (2018) Metabolomics and lipidomics study of mouse models of type 1 diabetes highlights divergent metabolism in purine and tryptophan metabolism prior to disease onset. J Proteome Res 17(3):946–960
Nagayach A, Patro N, Patro I (2014) Astrocytic and microglial response in experimentally induced diabetic rat brain. Metab Brain Dis 29(3):747–761
Nobuo S (1994) Cytochrome P450 changes in rats with streptozocin-induced diabetes. Int J Biochem 26:1261–1268
Palazzo E, Luongo L, Guida F, Marabese I, Romano R, Iannotta M et al (2016) D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. Amino Acids 48(7):1553–1567
Pereira FC, Rolo MR, Marques E, Mendes VM, Ribeiro CF, Ali SF et al (2008) Acute increase of the glutamate–glutamine cycling in discrete brain areas after administration of a single dose of amphetamine. Ann NY Acad Sci 1139(1):212–221
Pugliese M, Carrasco JL, Andrade C, Mas E, Mascort J, Mahy N (2005) Severe cognitive impairment correlates with higher cerebrospinal fluid levels of lactate and pyruvate in a canine model of senile dementia. Prog Neuro-Psychopharmacol Biol Psych 29(4):603–610
Savorani F, Tomasi G, Engelsen SB (2010) icoshift: A versatile tool for the rapid alignment of 1D NMR spectra. J Magn Reson 202(2):190–202
Schurr A, Payne RS, Miller JJ, Rigor BM (1997) Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. J Neurochem 69(1):423–426
Shemesh N, Rosenberg JT, Dumez JN, Grant SC, Frydman L (2017) Distinguishing neuronal from astrocytic subcellular microstructures using in vivo Double Diffusion Encoded 1H MRS at 21.1 T. PloS One 12(10):e0185232
Shingo AS, Kanabayashi T, Murase T, Kito S (2012) Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behav Brain Res 229(2):378–383
Stern DM, Yan SD, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 1(1):1–15
Thielen JW, Gancheva S, Hong D, Rohani Rankouhi S, Chen B, Apostolopoulou M et al (2019) Higher GABA concentration in the medial prefrontal cortex of Type 2 diabetes patients is associated with episodic memory dysfunction. Hum Brain Mapp 40:4287–4295
Van Bussel FC, Backes WH, Hofman PA, Puts NA, Edden RA, Van Boxtel MP et al (2016) Increased GABA concentrations in type 2 diabetes mellitus are related to lower cognitive functioning. Medicine 95:e4803
Van Duinkerken E, Schoonheim MM, Sanz-Arigita EJ, IJzerman RG, Moll AC, Snoek FJ et al (2012) Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes 61:1814–1821
Wessels AM, Rombouts SA, Remijnse PL, Boom Y, Scheltens P, Barkhof F et al (2007) Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 50:1763–1769
Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vázquez-Fresno R et al (2017) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46:D608–D617
Yagihashi S, Mizukami H, Sugimoto K (2011) Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Invest 2(1):18–32
Yao H, Sadoshima S, Nishimura Y, Fujii K, Oshima M, Ishitsuka T et al (1989) Cerebrospinal fluid lactate in patients with diabetes mellitus and hypoglycaemic coma. J Neurol Neurosur Psychiat 52:372–375
Zafra F, Ibáñez I, Bartolomé-Martín D, Piniella D, Arribas-Blázquez M, Giménez C (2017) Glycine transporters and its coupling with NMDA receptors. Adv Neurobiol 16:55–83
Zhao L, Dong M, Ren M, Li C, Zheng H, Gao H (2018) Metabolomic analysis identifies lactate as an important pathogenic factor in diabetes-associated cognitive decline rats. Mol Cell Proteom 17(12):2335–2346
Zheng H, Lin Q, Wang D, Xu P, Zhao L, Hu W et al (2017a) NMR-based metabolomics reveals brain region-specific metabolic alterations in streptozotocin-induced diabetic rats with cognitive dysfunction. Metab Brain Dis 32(2):585–593
Zheng H, Zheng Y, Wang D, Cai A, Lin Q, Zhao L et al (2017c) Analysis of neuron–astrocyte metabolic cooperation in the brain of db/db mice with cognitive decline using 13C NMR spectroscopy. J Cereb Blood Flow Metab 37(1):332–343
Zheng H, Zheng Y, Zhao L, Chen M, Bai G, Hu Y et al (2017b) Cognitive decline in type 2 diabetic db/db mice may be associated with brain region-specific metabolic disorders. BBA-Mol Basis Dis 1863(1):266–273
Zheng H, Zhou Q, Du Y, Li C, Xu P, Lin L et al (2018) The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer’s disease. BBA-Mol Basis Dis 1864(1):263–273
Zhu YB, Gao W, Zhang Y, Jia F, Zhang HL, Liu YZ et al (2016) Astrocyte-derived phosphatidic acid promotes dendritic branching. Sci Rep 6:21096
Funding
This study was supported by the National Natural Science Foundation of China (Nos.: 21605115 and 81771386), Health Foundation for Creative Talents in Zhejiang Province (2016), Project Foundation for the College Young and Middle-aged Academic Leader of Zhejiang Province (2017) and Wenzhou Bureau of Science and Technology (No.: Y20150087).
Author information
Authors and Affiliations
Contributions
YJY, HZ and HCG contributed to the experimental design. TTZ, KF and NZX contributed to animal experiments. TTZ, KF, JCL and CWY contributed to the sample collection and NMR metabolomic analysis. HZ and HCG contributed to the data analysis, result interpretation and writing. All authors have read, revised and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 285 kb)
Rights and permissions
About this article
Cite this article
Zhang, T., Zheng, H., Fan, K. et al. NMR-based metabolomics characterizes metabolic changes in different brain regions of streptozotocin-induced diabetic mice with cognitive decline. Metab Brain Dis 35, 1165–1173 (2020). https://doi.org/10.1007/s11011-020-00598-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-020-00598-z